Page 11 - Pharma Sector

FIIs buy BFSI, telecom, metal stocks in March 2025; should you too?

Banking, financial services, and insurance (BFSI), telecom, and metals saw the highest FII flows in March 2025

Biocon subsidiary gets USFDA nod for Everolimus tablets; share zooms 6%

The rise in the Biocon share price came after its wholly-owned unit, Biocon Pharma, received USFDA nod for Everolimus tablets.

Cipla share price jumps 5% as USFDA okays cancer drug Paclitaxel

Cipla said USFDA has approved the ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial ('Protein-bound Paclitaxel') on Apr 10

Here's why Sun Pharma share price advanced 5% in trade on April 11; details

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of Leqselvi (deuruxolitinib).

Govt may fast-track food, medicines, farm trade under AEO framework

The AEO programme is implemented by the Central Board of Indirect Taxes and Customs (CBIC) under the aegis of the World Customs Organization's SAFE Framework

5 pharma stocks that you should stay away from given their tech charts

Technical charts hint that pharma shares such as Cipla, Lupin, Sun Pharma, Zydus Lifesciences and Gland Pharma could slide up to 23% as Trump tariff threat on pharma import looms.

Booster shot as India's pharma market grew 8.4% in FY25: Pharmarack

Augmentin remains top-selling medicine brand at Rs 816 crore sales

Here's why Dr. Reddy's share slipped 8%, hit 52-week low on Monday, April 7

The fall in Dr. Reddy's share price came after the company announced that it received approximately Rs 2,395-crore show cause notice from I-T department

Pharma companies likely to pass on costs in US as fresh levy looms

Brokerages also felt that the pharma companies will aim to pass on the tariff hike to payors

Higher tariffs may significantly dent profits of pharma companies

Companies such as Sun Pharma which have a significant specialty portfolio could be less impacted than Indian peers in the US market given lower competition in niche segments

Emcure arm Tillomed acquires Manx Pharma portfolio for Rs 218.67 cr

The deal includes the purchase of product dossiers, marketing authorisations, intellectual property, and inventory

Trump says tariffs on chips and pharma imports to be announced soon

President Trump has said tariffs on pharmaceutical and semiconductor imports will be announced shortly, as the US imposes a 27% duty on all imports from India

Here's why Medicamen Biotech shares skyrocketed 12% in trade on April 3

Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.

Pharma, semiconductors escape Trump's tariffs. See full exemption list here

Pharmaceuticals, semiconductors, and other goods are exempt from Trump's tariffs, as the White House releases a full list ahead of the April 5 implementation

India's pharma industry gets relief from Trump's reciprocal tariff

US President says India imposes 52% tariff on American imports and engages in currency manipulation and non-tariff barriers

US businesses get ready for more pain as Trump rolls out reciprocal tariffs

The US will now impose a 10 per cent baseline tariff on all imports to the country effective April 5 and higher duties on several of its biggest trading partners

Drug prices may rise in US if Indian pharma firms pass on Trump's tariff

The US administration has not made announcements yet on sector-specific tariffs

'Scenario building' in Indian Pharma Inc ahead of US tariff announcement

Pharmaceutical products have been on the radar of US President Donald Trump, who has indicated that tariffs of up to 25 per cent could be imposed on this category

US tariffs may hit agri, machinery, pharma, electrical sectors: Experts

Goods from sectors, including agriculture, precious stones, chemicals, pharma, medical devices, electricals, and machinery may get impacted if the US will go ahead with imposing reciprocal tariffs on Indian products, according to experts. They said that these sectors could face additional customs duties from the Trump administration because of the high tariff differential or gap, which is the difference between the import duties imposed by the US and India on a product. At the broad sector level, the potential tariff gaps between India and the US vary across the sectors. The gap is 8.6 per cent for chemicals and pharmaceuticals; 5.6 per cent for plastics; 1.4 per cent for textiles and clothing; 13.3 per cent for diamonds, gold, and jewellery; 2.5 per cent for iron, steel, and base metals; 5.3 per cent for machinery and computers; 7.2 per cent for electronics; and 23.1 per cent for automobiles and auto components. "The higher the tariff gap, the worse affected a sector could be," an

Agilus Diagnostics lowers marketing spend 2 years after rebranding

In FY25, an additional Rs 50 crore was spent on marketing over and above the usual budget